The Healthcare Economy and Challenges Faced in Procurement – How Greiner Bio-One Helps
The healthcare market sector is incredibly dynamic and if we have learnt anything from the past few years, then it is that manufacturers need to be able to react fast when called upon. As we have read in a previous article (Why strategic partnerships with suppliers are key to a successful procurement strategy), if the usual supply chain breaks down, purchasers in clinical healthcare may need to make rapid decisions to ensure that sufficient supplies and materials are available. Thus, preventing daily operations from being interrupted and maintaining the provision of healthcare.
Why Greiner Bio-One plays an active role!
Decision making in a dynamic, fast paced environment with the additional burden that decisions may have an influence on the health and wellbeing of a person in the care of your facility is an enormous responsibility.
Greiner Bio-One, as a leading manufacturer in the medical device sector, plays an active role in helping customers to shoulder this burden.
During the pandemic, amongst an atmosphere of fear and panic due to uncertainty and shortages, it became clear that to enable essential faster reaction times, it was necessary to bring all teams involved in daily operations closer. It was at this time that the concept of a constantly updated KPI (key performance indicator) dashboard as well as global S &OP (Sales and Operation Planning) was initiated.
This enabled monitoring and transparency of daily operational business as well as aligned sales and supply plans for critical product groups through a global lens. To ensure the best possible supply to customers worldwide, the dashboard gave an overview of the whole value chain, from the incoming orders, enabling continuous analysis of customer and market needs, up to the production output and any backorder situation, providing immediate identification of pain points.
Greiner Bio-One: A competent and trusted partner
A system born in a time of crisis has developed into a highly intelligent system still in use today and still being perfected and improved upon. This makes Greiner Bio-One an extremely competent and trusted partner in the healthcare sector. With the KPI dashboard, fed by information from all of Greiner Bio-One’s global facilities, market trends and reactions are recognised ahead of time, enabling an understanding of why interest in certain product lines are developing or diminishing. With this tool, Greiner Bio-One has the capacity to better monitor a market situation and evaluate if questions need to be asked. For example, if an epidemic is reported, that may cause fear, resulting in sudden bulk buying, or acute additional needs, for example. This order behaviour analysis means that the most suitable operational measures can be derived on a daily basis, whether that be to switch focus on a particular product or to ramp down others, and even enabled production planning across continents. Global cooperation is fostered, and risk management is increasingly better aligned.
Greiner Bio-One Preanalytics has production facilities on continents across the world, in Europe, Asia, North and South America, as well as warehouse facilities at sales subsidiaries in many other countries. Greiner Bio-One has always highly valued these short supply and localised delivery paths, and in providing this network, we have been a pioneer in keeping carbon footprint as low as possible.
However, a crucial lesson from the past few years has been to consider the balance between preservation of the environment and being in a position to ensure lean reactions to adverse medical situations. The global KPI dashboard has meant that global subsidiaries have been able to support each other at times of shortage and emergency, serving customers in the healthcare industry when the need is most acute.
Greiner Bio-One will continue to analyse and optimise operations, ensuring that as far as possible the environmental footprint remains a priority alongside efficient supply and benefit to customers.
Safety and value, it’s in our blood
Protecting patients, clinicians and accuracy are topics to be covered in more detail here in the coming months. To ensure you don’t miss out, subscribe to the series here.
Please select your intention and contact the person who is responsible for you!
Disclaimer
This product information is addressed exclusively to healthcare professionals. Devices of Greiner Bio-One are to be used by properly trained healthcare professionals only in accordance with the relevant Instructions for Use (IFU). For a listing of indications, contraindications, precautions and warnings, please refer to the Instructions for Use which accompanies each product or is available for download from our website at www.gbo.com (Download Center). For more information contact your local Greiner Bio-One sales representative or visit our website.
All information is provided without guarantee despite careful processing. Any liability, warranty or guarantee of Greiner Bio-One GmbH is excluded. All rights, errors and changes are reserved. If not stated otherwise, Greiner Bio-One GmbH has all copyrights and/or other (user-)rights in this documents, in particular to signs such as the mentioned (word-picture-)brands and logos. Any use, duplication or any other use of the rights of Greiner Bio-One GmbH is expressly prohibited.
Testimonials appearing on this blog communicate their individual experiences regarding the use of our products and/or services. The opinions expressed in this publication are those of the interview partner; they do not purport to reflect the opinions or views of Greiner Bio-One.
This information partly expresses opinions of our customers and/or experiences of individuals and do not purport to reflect the opinions or views of Greiner Bio-One.
Media owner and publisher: Greiner Bio-One GmbH, Bad Haller Str. 32, 4550 Kremsmünster
